Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease therapeutics,...
Dirk Thye Us Food Drug Administration Exchange Commission International Cooperative Ataxia Rating Scale Rm Quince Therapeutics Inc Securities Exchange
Source: marketscreener.com